uncategorized ยท 1/9/2013

Neste Jacobs and National Bioproducts Institute sign a biopharma agreement

Neste Jacobs Oy
Press release
9 January 2013 at 9.00 am

Neste Jacobs and National Bioproducts Institute sign a biopharma agreement

Technology, engineering and project management company Neste Jacobs Oy and the South African plasma fractionation company National Bioproducts Institute have signed a service agreement covering production consulting, engineering and executing of services related to plasma fractionation processes.

Under the agreement Neste Jacobs will carry out engineering, procurement, construction/installation, qualification, and validation services for National Bioproducts Institute in South Africa. Neste Jacobs' expertise in plasma fractionation unit operations, operational aspects and knowledge of particular features of plasma fractionation processes has made the company a leading partner in the field. The agreement between the two companies aligns with Neste Jacobs' strategy to assist governments and other health care providers worldwide to become self-sufficient in the manufacture of blood plasma products.

"We are very happy to co-operate with National Bioproducts Institute. Blood plasma fractionation is a substantial and growing part of our business and, together with our other core competences, ensures our growth globally," says Neste Jacobs' Managing Director Jarmo Suominen.

"We have been very satisfied with Neste Jacobs' delivery and performance and based on this experience they were a natural choice for us," says David Stubbings, the CEO of National Bioproducts Institute. "We wanted a strong partner with solid experience in the plasma products industry and in this respect Neste Jacobs was our first choice."

Neste Jacobs Oy

Jarmo Suominen
Managing Director

For more information, please contact:
Jarmo Suominen, Managing Director, Neste Jacobs Oy, tel. +358 50 458 3399
David Stubbings, CEO, National Bioproducts Institute, tel. + 27 3-1714 6700

Neste Jacobs in brief
Neste Jacobs is a preferred solution provider of high-quality technology, engineering, and project services for a wide range of industries in the chemicals and biotechnology fields. We have more than 50 years of experience in technology development and industrial investment projects in Europe, North America, Asia and the Middle East, and are looking to grow in the expanding markets in particular. Neste Jacobs' specific plasma fractionation experience dates back to the late 1970's, since when we have provided successful plasma fractionation solutions for our customers. We employ some 1,000 professionals globally.

National Bioproducts Institute in brief
National Bioproducts Institute is a not-for-profit company, whose core business is the manufacture of pharmaceutical products from human plasma, using a process of protein fractionation. As a registered pharmaceutical manufacturer, NBI is committed to the manufacture of safe, effective and high quality plasma-derived pharmaceutical products that provide life-saving therapy and improve the quality of life of patients with rare and serious diseases in South and Sub-Saharan Africa.